These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 207775)

  • 1. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue.
    Paque RE; Gauntt CJ; Nealon TJ; Trousdale MD
    J Immunol; 1978 May; 120(5):1672-8. PubMed ID: 207775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis.
    Paque RE; Straus DC; Nealon TJ; Gauntt CJ
    J Immunol; 1979 Jul; 123(1):358-64. PubMed ID: 221592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
    Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
    Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cell-mediated immunity against coxsackievirus B3-induced myocarditis in a primate model (Papio papio).
    Paque RE; Gauntt CJ; Nealon TJ
    Infect Immun; 1981 Jan; 31(1):470-9. PubMed ID: 6260666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
    Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
    Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackievirus B3 infection promotes generation of myeloid dendritic cells from bone marrow and accumulation in the myocardium.
    Chen P; Chen R; Yang Y; Yu Y; Xie Y; Zou Y; Ge J; Chen H
    Int Immunopharmacol; 2009 Oct; 9(11):1304-12. PubMed ID: 19664723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immune responses in mice challenged with an amyocarditic variant of Coxsackievirus B3.
    Lutton CW; Gudvangen RJ; Nealon TJ; Paque RE; Gauntt CJ
    J Med Virol; 1985 Dec; 17(4):345-57. PubMed ID: 3001222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of murine coxsackievirus-induced myocarditis utilizing anti-idiotypes.
    Paque RE; Miller R
    Viral Immunol; 1987-1988; 1(3):207-24. PubMed ID: 3509677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis.
    Godeny EK; Gauntt CJ
    J Immunol; 1986 Sep; 137(5):1695-702. PubMed ID: 3018079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model.
    Trousdale MD; Paque RE; Nealon T; Gauntt CJ
    Infect Immun; 1979 Feb; 23(2):486-95. PubMed ID: 217832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
    Leipner C; Borchers M; Merkle I; Stelzner A
    J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac deletion of the Coxsackievirus-adenovirus receptor abolishes Coxsackievirus B3 infection and prevents myocarditis in vivo.
    Shi Y; Chen C; Lisewski U; Wrackmeyer U; Radke M; Westermann D; Sauter M; Tschöpe C; Poller W; Klingel K; Gotthardt M
    J Am Coll Cardiol; 2009 Apr; 53(14):1219-26. PubMed ID: 19341864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
    Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
    J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
    Xu W; Shen Y; Chen RZ; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
    Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
    J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.